Business Intelligence Reports
Diagnostics | Information technology | Telemedicine

United Kingdom Medical Equipment Markets
Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012

Publication date: March 2009 Publisher: Global Markets Direct Product type: Report Pages: 501

Price: £1,310.00 approximately: $1,996 | €1,481 Buy and download >> (goes to Piribo's report-buying service)

This report is an essential source for in-depth information and data relating to the UK medical equipment market. The report provides an overview of the market structure, healthcare system, regulatory environment, reimbursement policies, distribution structure and trade associations for the UK medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share; and news, financial deals, pipeline products information by medical equipment sector.

Scope

• The report provides an overview of the medical equipment industry in UK and provides data and information on each of the key industries - cardiovascular devices, orthopedic devices, anesthesia and respiratory devices, patient monitoring devices, ophthalmic devices, hospital supplies, dental devices, diagnostic imaging devices, endoscopy devices, and in-vitro diagnostics.
• It details the healthcare system, market structure, regulatory environment, reimbursement policies, distribution structure and trade associations for UK medical equipment market.
• It also provides detailed data on market size by volume and value, key company share information for leading competitors in the market, revenues by distribution channel, and forecasts of market values.
• All figures are based on rigorous research methodologies including in-depth primary and secondary research.

Reasons to buy

• A single source to fulfill all of your business and competitor intelligence needs
• Gain a strong understanding of the country's medical industry and the 18 key sectors within it.
• Evaluate the attractiveness of the geography for medial equipment investment in the light of government policies and the reimbursement regime.
• Identify growth segments and opportunities in the industry.
• Analyze the competitiveness of the market and target the shares of key competitors.
• Develop strategies based on the latest product, brand, and regulatory events.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.
• Identify and analyze the strengths and weaknesses of the industry incumbents.

Buy and download >>

Contents

• 2 Introduction
• 3 Definitions of Markets Covered in the Report
• 4 Healthcare Sector Review
• 5 Regulation System
• 6 Pricing and Reimbursement
• 7 Distribution Structure
• 8 United Kingdom Medical Equipment Cross Market Comparison
• 9 Healthcare IT in United Kingdom
• 10 Cardiovascular Devices In United Kingdom
• 11 In Vitro Diagnostics In United Kingdom
• 12 Ophthalmic Devices In United Kingdom
• 13 Drug Delivery Devices In United Kingdom
• 14 Orthopedic Devices In United Kingdom
• 15 Hospital Supplies In United Kingdom
• 16 Nephrology and Urology Devices In United Kingdom
• 17 Wound Care Management In United Kingdom
• 18 Anesthesia and Respiratory Devices In United Kingdom
• 19 Dental Devices In United Kingdom
• 20 Diabetes Care Devices In United Kingdom
• 21 Patient Monitoring In United Kingdom
• 22 ENT Devices In United Kingdom
• 23 Surgical Equipment In United Kingdom
• 24 Endoscopy Devices In United Kingdom
• 25 Neurology Devices In United Kingdom
• 26 Diagnostic Imaging in United Kingdom
• 27 Overview of Key Companies in United Kingdom Medical Equipment Markets
• 28 Dade Behring Holdings, Inc. Company Profile
• 29 Appendix
• 1.1 List of Tables
  • Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
  • Table 2: Medical Device Approval Fee in UK, 2006
  • Table 3: United Kingdom, Medical Equipment Markets Comparison
  • Table 4: Healthcare IT Cross Country Comparison (2000-2012)
  • Table 5: Healthcare IT, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Table 6: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 7: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 8: Hospital Information Systems, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 9: Storage and Communication Systems, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 10: Healthcare IT, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 11: Hospital Information Systems, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 12: Storage and Communication Systems, United Kingdom, Company SHARE by Revenue ($ mn), 2006-2007
  • Table 13: Cardiovascular Devices Cross Country Comparison (2000-2012)
  • Table 14: Cardiovascular Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Table 15: Cardiovascular Devices Market, United Kingdom, Portfolio Analysis
  • Table 16: Cardiovascular Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 17: Cardiovascular Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 18: Cardiovascular Devices, United Kingdom, Overall Volume(Units), 2000-2012
  • Table 19: Cardiovascular Devices, United Kingdom, Overall Volume(Units), Historic, 2000-2007
  • Table 20: Cardiovascular Devices, United Kingdom, Overall Volume(Units), Forecast, 2007-2012
  • Table 21: Cardiac Rhythm Management, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 22: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 23: Cardiovascular Prosthetic Devices, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 24: Cardiovascular Surgery, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 25: Interventional Cardiology, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 26: Peripheral Vascular Devices, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 27: Cardiovascular Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 28: Cardiac Rhythm Management, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 29: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 30: Cardiovascular Prosthetic Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 31: Cardiovascular Surgery, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 32: Interventional Cardiology, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 33: Peripheral Vascular Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 34: In Vitro Diagnostics Cross Country Comparison (2000-2012)
  • Table 35: In Vitro Diagnostics, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Table 36: In Vitro Diagnostics Market, United Kingdom, Portfolio Analysis
  • Table 37: In Vitro Diagnostics, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 38: In Vitro Diagnostics, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 39: Blood Test Reagents, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 40: Clinical Chemistry Test Reagents, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 41: Genetic Test Reagents, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 42: Immunochemistry Test Reagents, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 43: Infectious Immunology Test Reagents, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 44: Instruments, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 45: Microbiology Test Reagents, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 46: Self Testing, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 47: In Vitro Diagnostics, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 48: Blood Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 49: Clinical Chemistry Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 50: Genetic Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 51: Immunochemistry Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 52: Infectious Immunology Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 53: Instruments, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 54: Microbiology Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 55: Self Testing, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 56: Ophthalmic Devices Cross Country Comparison (2000-2012)
  • Table 57: Ophthalmic Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Table 58: Ophthalmic Devices Market, United Kingdom, Portfolio Analysis
  • Table 59: Ophthalmic Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 60: Ophthalmic Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 61: Ophthalmic Devices, United Kingdom, Overall Volume(Units), 2000-2012
  • Table 62: Ophthalmic Devices, United Kingdom, Overall Volume(Units), Historic, 2000-2007
  • Table 63: Ophthalmic Devices, United Kingdom, Overall Volume(Units), Forecast, 2007-2012
  • Table 64: Cataract Surgery, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 65: Refractive Surgery, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 66: Vision Care, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 67: Ophthalmic Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 68: Cataract Surgery, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 69: Refractive Surgery, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 70: Vision Care, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 71: Drug Delivery Devices Cross Country Comparison (2000-2012)
  • Table 72: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Table 73: Drug Delivery Devices Market, United Kingdom, Portfolio Analysis
  • Table 74: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 75: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 76: Drug Delivery Devices, United Kingdom, Overall Volume(Units), 2000-2012
  • Table 77: Drug Delivery Devices, United Kingdom, Overall Volume(Units), Historic, 2000-2007
  • Table 78: Drug Delivery Devices, United Kingdom, Overall Volume(Units), Forecast, 2007-2012
  • Table 79: Infusion Systems, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 80: Inhalation Systems, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 81: Needle Free Injections, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 82: Drug Delivery Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 83: Infusion Systems, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 84: Inhalation Systems, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 85: Needle Free Injections, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 86: Orthopedic Devices Cross Country Comparison (2000-2012)
  • Table 87: Orthopedic Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Table 88: Orthopedic Devices Market, United Kingdom, Portfolio Analysis
  • Table 89: Orthopedic Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 90: Orthopedic Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 91: Orthopedic Devices, United Kingdom, Overall Volume(Units), 2000-2012
  • Table 92: Orthopedic Devices, United Kingdom, Overall Volume(Units), Historic, 2000-2007
  • Table 93: Orthopedic Devices, United Kingdom, Overall Volume(Units), Forecast, 2007-2012
  • Table 94: Arthroscopy, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 95: Joint Reconstruction, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 96: Orthobiologics, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 97: Orthopedic Accessories, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 98: Orthopedic Braces and Supports, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 99: Spinal Surgery, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 100: Trauma Fixation, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 101: Orthopedic Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 102: Arthroscopy, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 103: Joint Reconstruction, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 104: Orthobiologics, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 105: Orthopedic Accessories, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 106: Orthopedic Braces and Supports, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 107: Spinal Surgery, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 108: Trauma Fixation, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
  • Table 109: Hospital Supplies Cross Country Comparison (2000-2012)
  • Table 110: Hospital Supplies, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Table 111: Hospital Supplies Market, United Kingdom, Portfolio Analysis
  • Table 112: Hospital Supplies, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
• 1.2 List of Figures
  • Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006
  • Figure 2: Flowchart for Classification of Non-invasive Devices in UK, 2007
  • Figure 3: Flowchart for Classification of Invasive Devices in UK, 2007
  • Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007
  • Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007
  • Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007
  • Figure 7: Flowchart for Classification of Active Devices in UK, 2007
  • Figure 8: Flowchart for Classification of Active Devices in UK, 2007
  • Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
  • Figure 10: Conformity Assessment of Class-I Medical Devices in UK, 2007
  • Figure 11: Conformity Assessment of Class-IIa Medical Devices in UK, 2007
  • Figure 12: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
  • Figure 13: Conformity Assessment of Class-III Medical Devices in UK, 2007
  • Figure 14: United Kingdom, Medical Equipment Market Comparison,2007
  • Figure 15: Healthcare IT Cross Country Comparison (2000-2012)
  • Figure 16: Healthcare IT, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 17: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 18: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 19: Healthcare IT, United Kingdom, Company Share (%), 2007
  • Figure 20: Hospital Information Systems, United Kingdom, Company Share (%), 2007
  • Figure 21: Storage and Communication Systems, United Kingdom, Company Share (%), 2007
  • Figure 22: Cardiovascular Devices Cross Country Comparison (2000-2012)
  • Figure 23: Cardiovascular Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 24: Cardiovascular Devices Market, United Kingdom, Portfolio Analysis
  • Figure 25: Cardiovascular Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 26: Cardiovascular Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 27: Cardiovascular Devices, United Kingdom, Overall Volume(Units), 2000-2012
  • Figure 28: Cardiovascular Devices, United Kingdom, Overall Volume(Units), Historic, 2000-2007
  • Figure 29: Cardiovascular Devices, United Kingdom, Overall Volume(Units), Forecast, 2007-2012
  • Figure 30: Cardiovascular Devices, United Kingdom, Company Share (%), 2007
  • Figure 31: Cardiac Rhythm Management, United Kingdom, Company Share (%), 2007
  • Figure 32: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Company Share (%), 2007
  • Figure 33: Cardiovascular Prosthetic Devices, United Kingdom, Company Share (%), 2007
  • Figure 34: Cardiovascular Surgery, United Kingdom, Company Share (%), 2007
  • Figure 35: Interventional Cardiology, United Kingdom, Company Share (%), 2007
  • Figure 36: Peripheral Vascular Devices, United Kingdom, Company Share (%), 2007
  • Figure 37: In Vitro Diagnostics Cross Country Comparison (2000-2012)
  • Figure 38: In Vitro Diagnostics, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 39: In Vitro Diagnostics Market, United Kingdom, Portfolio Analysis
  • Figure 40: In Vitro Diagnostics, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 41: In Vitro Diagnostics, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 42: In Vitro Diagnostics, United Kingdom, Company Share (%), 2007
  • Figure 43: Blood Test Reagents, United Kingdom, Company Share (%), 2007
  • Figure 44: Clinical Chemistry Test Reagents, United Kingdom, Company Share (%), 2007
  • Figure 45: Genetic Test Reagents, United Kingdom, Company Share (%), 2007
  • Figure 46: Immunochemistry Test Reagents, United Kingdom, Company Share (%), 2007
  • Figure 47: Infectious Immunology Test Reagents, United Kingdom, Company Share (%), 2007
  • Figure 48: Instruments, United Kingdom, Company Share (%), 2007
  • Figure 49: Microbiology Test Reagents, United Kingdom, Company Share (%), 2007
  • Figure 50: Self Testing, United Kingdom, Company Share (%), 2007
  • Figure 51: Ophthalmic Devices Cross Country Comparison (2000-2012)
  • Figure 52: Ophthalmic Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 53: Ophthalmic Devices Market, United Kingdom, Portfolio Analysis
  • Figure 54: Ophthalmic Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 55: Ophthalmic Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 56: Ophthalmic Devices, United Kingdom, Company Share (%), 2007
  • Figure 57: Cataract Surgery, United Kingdom, Company Share (%), 2007
  • Figure 58: Refractive Surgery, United Kingdom, Company Share (%), 2007
  • Figure 59: Vision Care, United Kingdom, Company Share (%), 2007
  • Figure 60: Drug Delivery Devices Cross Country Comparison (2000-2012)
  • Figure 61: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 62: Drug Delivery Devices Market, United Kingdom, Portfolio Analysis
  • Figure 63: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 64: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 65: Drug Delivery Devices, United Kingdom, Overall Volume(Units), 2000-2012
  • Figure 66: Drug Delivery Devices, United Kingdom, Overall Volume(Units), Forecast, 2007-2012
  • Figure 67: Drug Delivery Devices, United Kingdom, Company Share (%), 2007
  • Figure 68: Infusion Systems, United Kingdom, Company Share (%), 2007
  • Figure 69: Inhalation Systems, United Kingdom, Company Share (%), 2007
  • Figure 70: Needle Free Injections, United Kingdom, Company Share (%), 2007
  • Figure 71: Orthopedic Devices Cross Country Comparison (2000-2012)
  • Figure 72: Orthopedic Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 73: Orthopedic Devices Market, United Kingdom, Portfolio Analysis
  • Figure 74: Orthopedic Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 75: Orthopedic Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 76: Orthopedic Devices, United Kingdom, Company Share (%), 2007
  • Figure 77: Arthroscopy, United Kingdom, Company Share (%), 2007
  • Figure 78: Joint Reconstruction, United Kingdom, Company Share (%), 2007
  • Figure 79: Orthobiologics, United Kingdom, Company Share (%), 2007
  • Figure 80: Orthopedic Accessories, United Kingdom, Company Share (%), 2007
  • Figure 81: Orthopedic Braces and Supports, United Kingdom, Company Share (%), 2007
  • Figure 82: Spinal Surgery, United Kingdom, Company Share (%), 2007
  • Figure 83: Trauma Fixation, United Kingdom, Company Share (%), 2007
  • Figure 84: Hospital Supplies Cross Country Comparison (2000-2012)
  • Figure 85: Hospital Supplies, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 86: Hospital Supplies Market, United Kingdom, Portfolio Analysis
  • Figure 87: Hospital Supplies, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 88: Hospital Supplies, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 89: Hospital Supplies, United Kingdom, Company share (%), 2007
  • Figure 90: Disposable Hospital Supplies, United Kingdom, Company share (%), 2007
  • Figure 91: Mobility Aids and Transportation Equipment, United Kingdom, Company share (%), 2007
  • Figure 92: Patient Examination Devices, United Kingdom, Company share (%), 2007
  • Figure 93: Sterilization and Disinfectant Equipment, United Kingdom, Company share (%), 2007
  • Figure 94: Syringes and Needles, United Kingdom, Company share (%), 2007
  • Figure 95: Nephrology and Urology Devices Cross Country Comparison (2000-2012)
  • Figure 96: Nephrology and Urology Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 97: Nephrology and Urology Devices Market, United Kingdom, Portfolio Analysis
  • Figure 98: Nephrology and Urology Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 99: Nephrology and Urology Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 100: Nephrology and Urology Devices, United Kingdom, Company Share (%), 2007
  • Figure 101: Incontinence Devices, United Kingdom, Company Share (%), 2007
  • Figure 102: Lithotripters, United Kingdom, Company Share (%), 2007
  • Figure 103: Renal Dialysis Equipment, United Kingdom, Company Share (%), 2007
  • Figure 104: Wound Care Management Cross Country Comparison (2000-2012)
  • Figure 105: Wound Care Management, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 106: Wound Care Management Market, United Kingdom, Portfolio Analysis
  • Figure 107: Wound Care Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 108: Wound Care Management, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 109: Wound Care Management, United Kingdom, Overall Volume(Units), 2000-2012
  • Figure 110: Wound Care Management, United Kingdom, Overall Volume(Units), Historic, 2000-2007
  • Figure 111: Wound Care Management, United Kingdom, Overall Volume(Units), Forecast, 2007-2012
  • Figure 112: Wound Care Management, United Kingdom, Company Share (%), 2007
  • Figure 113: Advanced Wound Management, United Kingdom, Company Share (%), 2007
  • Figure 114: Compression Therapy, United Kingdom, Company Share (%), 2007
  • Figure 115: Ostomy, United Kingdom, Company Share (%), 2007
  • Figure 116: Traditional Wound Management, United Kingdom, Company Share (%), 2007
  • Figure 117: Wound Closure Devices, United Kingdom, Company Share (%), 2007
  • Figure 118: Anesthesia and Respiratory Devices Cross Country Comparison (2000-2012)
  • Figure 119: Anesthesia and Respiratory Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 120: Anesthesia and Respiratory Devices Market, United Kingdom, Portfolio Analysis
  • Figure 121: Anesthesia and Respiratory Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 122: Anesthesia and Respiratory Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 123: Anesthesia and Respiratory Devices, United Kingdom, Company share (%), 2007
  • Figure 124: Anesthesia Disposables, United Kingdom, Company share (%), 2007
  • Figure 125: Anesthesia Machines, United Kingdom, Company share (%), 2007
  • Figure 126: Respiratory Devices, United Kingdom, Company share (%), 2007
  • Figure 127: Respiratory Disposables, United Kingdom, Company Share (%), 2007
  • Figure 128: Respiratory Measurement Devices, United Kingdom, Company share (%), 2007
  • Figure 129: Sleep Apnea Diagnostic Systems, United Kingdom, Company share (%), 2007
  • Figure 130: Dental Devices Cross Country Comparison (2000-2012)
  • Figure 131: Dental Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 132: Dental Devices Market, United Kingdom, Portfolio Analysis
  • Figure 133: Dental Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 134: Dental Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 135: Dental Devices, United Kingdom, Company Share (%), 2007
  • Figure 136: Dental Equipment, United Kingdom, Company Share (%), 2007
  • Figure 137: Dental Supplies, United Kingdom, Company Share (%), 2007
  • Figure 138: Digital Dental X-Ray Systems, United Kingdom, Company Share (%), 2007
  • Figure 139: Orthodontic Materials and Products, United Kingdom, Company Share (%), 2007
  • Figure 140: Diabetes Care Devices Cross Country Comparison (2000-2012)
  • Figure 141: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 142: Diabetes Care Devices Market, United Kingdom, Portfolio Analysis
  • Figure 143: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 144: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 145: Diabetes Care Devices, United Kingdom, Overall Volume(Units), 2000-2012
  • Figure 146: Diabetes Care Devices, United Kingdom, Overall Volume(Units), Historic, 2000-2007
  • Figure 147: Diabetes Care Devices, United Kingdom, Overall Volume(Units), Forecast, 2007-2012
  • Figure 148: Diabetes Care Devices, United Kingdom, Company share (%), 2007
  • Figure 149: Glucose Monitoring, United Kingdom, Company share (%), 2007
  • Figure 150: Insulin Delivery, United Kingdom, Company Share (%), 2007
  • Figure 151: Patient Monitoring Cross Country Comparison (2000-2012)
  • Figure 152: Patient Monitoring, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 153: Patient Monitoring Market, United Kingdom, Portfolio Analysis
  • Figure 154: Patient Monitoring, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 155: Patient Monitoring, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 156: Patient Monitoring, United Kingdom, Company Share (%), 2007
  • Figure 157: Micro-Electromechanical Systems, United Kingdom, Company Share (%), 2007
  • Figure 158: Multiparameter Patient Monitoring, United Kingdom, Company Share (%), 2007
  • Figure 159: Non-Invasive Blood Pressure Monitors, United Kingdom, Company Share (%), 2007
  • Figure 160: Remote Patient Monitoring, United Kingdom, Company Share (%), 2007
  • Figure 161: Wireless and Ambulatory Monitoring, United Kingdom, Company Share (%), 2007
  • Figure 162: ENT Devices Cross Country Comparison (2000-2012)
  • Figure 163: ENT Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 164: ENT Devices Market, United Kingdom, Portfolio Analysis
  • Figure 165: ENT Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 166: ENT Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 167: ENT Devices, United Kingdom, Company Share (%), 2007
  • Figure 168: Diagnostic Devices, United Kingdom, Company Share (%), 2007
  • Figure 169: Hearing Aid Devices, United Kingdom, Company Share (%), 2007
  • Figure 170: Hearing Implants, United Kingdom, Company Share (%), 2007
  • Figure 171: Surgical Equipment Cross Country Comparison (2000-2012)
  • Figure 172: Surgical Equipment, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 173: Surgical Equipment Market, United Kingdom, Portfolio Analysis
  • Figure 174: Surgical Equipment, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 175: Surgical Equipment, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 176: Surgical Equipment, United Kingdom, Company share (%), 2007
  • Figure 177: Electrosurgical Devices, United Kingdom, Company share (%), 2007
  • Figure 178: Hand Instruments, United Kingdom, Company share (%), 2007
  • Figure 179: Surgical Sutures, United Kingdom, Company share (%), 2007
  • Figure 180: Endoscopy Devices Cross Country Comparison (2000-2012)
  • Figure 181: Endoscopy Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 182: Endoscopy Devices Market, United Kingdom, Portfolio Analysis
  • Figure 183: Endoscopy Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 184: Endoscopy Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 185: Endoscopy Devices, United Kingdom, Overall Volume(Units), 2000-2012
  • Figure 186: Endoscopy Devices, United Kingdom, Overall Volume(Units), Historic, 2000-2007
  • Figure 187: Endoscopy Devices, United Kingdom, Overall Volume(Units), Forecast, 2007-2012
  • Figure 188: Endoscopy Devices, United Kingdom, Company Share (%), 2007
  • Figure 189: Flexible Endoscope, United Kingdom, Company Share (%), 2007
  • Figure 190: Rigid Endoscope, United Kingdom, Company Share (%), 2007
  • Figure 191: Neurology Devices Cross Country Comparison (2000-2012)
  • Figure 192: Neurology Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
  • Figure 193: Neurology Devices Market, United Kingdom, Portfolio Analysis
  • Figure 194: Neurology Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 195: Neurology Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 196: Neurology Devices, United Kingdom, Company Share (%), 2007
  • Figure 197: CSF Management, United Kingdom, Company Share (%), 2007
  • Figure 198: Interventional Neurology, United Kingdom, Company Share (%), 2007
  • Figure 199: Neurostimulation Devices, United Kingdom, Company Share (%), 2007
  • Figure 200: Neurosurgical Products (Neuroendoscopes), United Kingdom, Company Share (%), 2007
  • Figure 201: Diagnostic Imaging Cross Country Comparison (2000-2012)
  • Figure 202: Diagnostic Imaging, United Kingdom, Overall Revenue ($ mn), 2000-2012
  • Figure 203: Diagnostic Imaging, United Kingdom, Portfolio Analysis
  • Figure 204: Diagnostic Imaging, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2007
  • Figure 205: Diagnostic Imaging, United Kingdom, Overall Revenue ($ mn), Forecast, 2007-2012
  • Figure 206: Diagnostic Imaging, United Kingdom, Category Volume (Units), 2000-2012
  • Figure 207: Diagnostic Imaging, United Kingdom, Category Volume (Units), Historic, 2000-2007
  • Figure 208: Diagnostic Imaging, United Kingdom, Category Volume (Units), Forecast, 2007-2012
  • Figure 209: Diagnostic Imaging, United Kingdom Company Share (%), 2007
  • Figure 210: Computed Tomography Systems, United Kingdom, Company Share (%), 2007
  • Figure 211: Mammography Equipment, United Kingdom, Company Share (%), 2007
  • Figure 212: MRI Systems, United Kingdom, Company Share (%), 2007
  • Figure 213: Nuclear Imaging Equipment, United Kingdom, Company Share (%), 2007
  • Figure 214: Ultrasound Systems, United Kingdom, Company Share (%), 2007
  • Figure 215: X-Ray Systems, United Kingdom, Company Share (%), 2007
  • Figure 216: Medtronic, Inc. Value Chain Analysis
  • Figure 217: Boston Scientific Corporation Value Chain Analysis
  • Figure 218: St. Jude Medical Inc. Value Chain Analysis
  • Figure 219: Terumo Corporation Value Chain Analysis
  • Figure 220: Sorin Group Value Chain Analysis
  • Figure 221: Zimmer Holdings, Inc. Value Chain Analysis
  • Figure 222: Stryker Corporation Value Chain Analysis
  • Figure 223: Synthes, Inc. Value Chain Analysis
  • Figure 224: Biomet, Inc. Value Chain Analysis
  • Figure 225: Smith & Nephew Plc Value Chain Analysis
  • Figure 226: Covidien Ltd./Tyco Healthcare Value Chain Analysis
  • Figure 227: Smiths Medical Value Chain Analysis
  • Figure 228: Drager Medical AG & Co. KG Value Chain Analysis
  • Figure 229: Cardinal Health, Inc. Value Chain Analysis
  • Figure 230: Philips Medical Systems Value Chain Analysis
  • Figure 231: Siemens Medical Solutions Value Chain Analysis
  • Figure 232: Toshiba Medical Systems Corporation Value Chain Analysis
  • Figure 233: Hitachi Medical Corporation Value Chain Analysis
  • Figure 234: F. Hoffmann-La Roche Ltd Value Chain Analysis
  • Figure 235: Beckman Coulter, Inc. Value Chain Analysis
  • Figure 236: Abbott Laboratories Value Chain Analysis
  • Figure 237: Biomerieux Sa Value Chain Analysis
  • Figure 238: Global Markets Direct Methodology

Buy and download >>

More reports:
Diagnostics | Information technology | Telemedicine